Drug formulation | PF latanoprost (Monoprost®) | PF tafluprost (Taflotan®) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Irritation variable1 | Time point2 | 1 | 2 | 3 | 4 | 5 | 6 | mean±SD | 1 | 2 | 3 | 4 | 5 | 6 | mean±SD |
Conjunctival hyperemia | 30 minutes | 2 | 2 | 2 | 1 | 1 | 2 | 1.67±0.52 | 1 | 2 | 2 | 2 | 2 | 1 | 1.67±0.52 |
3 hours | 2 | 2 | 1 | 0 | 1 | 2 | 1.33±0.82 | 1 | 1 | 1 | 1 | 2 | 1 | 1.17±0.41 | |
5 hours | 1 | 2 | 1 | 0 | 0 | 1 | 0.83±0.754 | 0 | 0 | 0 | 0 | 1 | 1 | 0.33±0.52 | |
1 day | 0 | 1 | 0 | 0 | 0 | 0 | 0.17±0.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00±0.00 | |
Conjunctival swelling3 | 30 minutes | 1 | 1 | 0 | 0 | 0 | 0 | 0.33±0.52 | 0 | 0 | 1 | 0 | 1 | 0 | 0.33±0.52 |
3 hours | 1 | 0 | 0 | 0 | 0 | 0 | 0.17±0.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00±0.00 | |
Conjunctival discharge3 | 30 minutes | 2 | 2 | 0 | 0 | 0 | 0 | 0.67±1.03 | 0 | 0 | 0 | 1 | 2 | 0 | 0.50±0.84 |
3 hours | 1 | 0 | 0 | 0 | 0 | 0 | 0.17±0.41 | 0 | 0 | 0 | 0 | 1 | 0 | 0.17±0.41 |